Self Directed Surgical Procedures Through AI.
Healthcare Innovators and Healthcare Funders, MedsApp is the autonomous robotics platform that reduces procedure variability because it combines multi-modal sensing with closed-loop decisioning. Detection Inc, is seeking partners in various industries to test the MedsApp platform to showcase the AI technology. Patents pending in the medical, dental, cosmetic, ophthalmology , and veterinarian professions.
Detection Inc (Delaware) now owns from the prior research and development companies (and LLCs) all assets including trade secrets, UMMDA technology (2022 patents pending), Autonomous Medical Surgical Robotic AI and Machine Learning technologies, granted patents, pending patent applications, and biosurfactant technologies as well as the portfolio of domain names . Prior investors from start engine whom together as a group total under $25,000.00, will be transferred into Detection Inc series A voting stock with 5 times their investment (from their non-voting stock).
MedsApp.ai has developed a unique physical application (patent pending 12/25) whereby MedsApp robots are able to measure and construct through a 3D printer located next to a patient in a MedsApp medical procedure room prostheses and body parts in real time for quick robotic insertion. This application is also self directed and needs medical partners such as governmental entities.